Abstract
H. influenzae, whether capsulated or not, is able to activate both the classical and alternative pathways (Anderson et al, 1972; Quinn et al, 1977) resulting in the potential to generate bactericidal and opsonising activities. Most studies have investigated these activities in relationship to type b strains because of the importance of this serotype as a cause of life-threatening invasive infections in childhood. Anderson et al (1972) showed that either purified type b capsular polysaccharide (PRP) or non-capsulated H. influenzae organisms could absorb factors from human serum which were necessary for complement dependent bactericidal activity. Subsequent studies by Steele et al used affinity purified IgG antibodies and agammaglobulinaemic human serum from which factor D and properdin had been selectively inactivated to demonstrate that H. influenzae type b could be killed through classical pathway activities mediated by antibodies to PRP. Similarly, bactericidal activity could also be demonstrated using an IgG fraction from human sera that had been pre-adsorbed with PRP to remove anticapsular antibodies. Taken together, these studies suggested that antibodies to either the PRP capsule or to cell envelope constituents are able to activate the classical pathway and generate bactericidal activity.
Keywords
- Bactericidal Activity
- Alternative Pathway
- Haemophilus Influenzae
- Classical Pathway
- Complement Deficiency
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alper, C., Abramson, N., and Johnston, R.B. Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3). N. Engl. J. Med. 282: 349–354 (1970).
Anderson, P., Johnston, R.B. Jr., and Smith, D.H. Human serum activities against Haemophilus influenzae type b. J. Clin. Invest. 51: 31–38 (1972).
Anderson, P., Flesher, A., Shaw, S., Harding, L.A., and Smith, D.H. Phenotypic and genetic variation in the susceptibility of Haemophilus influenzae type b to antibodies to somatic antigens. J. Clin. Invest. 65: 885–891 (1980)
Ballow, M. Shira,.E., Harden, L., Yang, S.Y., and Day, N.K. Complete absence of the third component of complement in man. J. Clin. Invest. 56: 703–710 (1975)
Corrall, C.J., Winkelstein, J.A., Moxon, E.R. Participation of complement in host defense against encapsulated Haemophilus influenzae types a, c, and d. Infect. Immun. 35: 759–763 (1982).
Crosson, F.J. Jr., Winkelstein, J.A., and Moxon, E.R. Participation of complement in the non-immune host defense against Haemophilus influenzae type b septicemia and meningitis. Infect. Immun. 14: 882–887 (1976).
Ely, S., Tippett, J., and Kroll, J.S., and Moxon, E.R. Mutations affecting expression and maintenance of genes encoding the serotype b capsule of Haemophilus influenzae. J. Bact. 167: 44–48 (1986).
Eng, R.H.K., Seligman, S.J., Arnout, M.A., and Alper, C.R. Variable expression of homozygous C3b inactivator deficiency. Clin. Res. 26: 394A (1978).
Johnston, R.B. Jr., Anderson, P., and Newman, S.L. Opsonization and
phagocytosis of Haemophilus influenzae type b. In: Sell, S.H.W., Karzon, D.T. (eds.) Haemophhilus influenzae. Nashville: Vanderbilt University Press, pp. 99–112 (1973a).
Johnston, R.B. Jr., Anderson, P., Rosen, F.S., and Smith, D.H. Characterization of human antibody to polyribose-phosphate, the capsular antigen of Haemophilus influenzae type b. Clin. Immunol. Immunopath. 1: 234–240 (1973b).
Kimura, A. and Hansen, E.J. Antigenic and phenotypic variations of Haemophilus influenzae type b lipopolysaccharide and their relationship to virulence. Infect. Immun. 51: 69–79 (1986).
Moxon, E.R., Deich, R.A. and Connelly, C.J. Cloning of chromosomal DNA from Haemophilus influenzae: Its use for studying the expression of type b capsule and virulence. J. Clin. Invest. 73: 298–306 (1984).
Musher, D.M., Hague-Park, M., Baughn, R.E., Wallace, R.J., and Cowley, B. Opsonizing and bactericidal effects of normal human serum on non-typable Haemophilus influenzae. Infect. Immun. 39: 297–304 (1983).
Musher, D.M., Kubitschek, K.R., Crennan, J., and Baughn, R.E. Pneumonia and acute febrile tracheobronchitis due to Haemophious influenzae. Ann. Intern. Med. 99: 444–450 (1983).
Quinn, P.H., Crosson, F.J., Winkelstein, J.A., and Moxon, R.W. Activation of the alternative complement pathway by Haemophilus influenzae, type b. Infect. Immun. 16: 400–402 (1977).
Shaw, S., Smith, A.L., Anderson, P., and Smith, D.H. The paradox of Haemophilus influenzae, type b, bacteremia in the presence of serum bactericidal activity. J. Clin. Invest. 58:1019–1029 (1976).
Steele, N.P., Munson, R.S. Jr., Granoff, D.M., and Cummins, J.E., and Levine, R.P. Antibody-dependent alternative pathway killing of Haemophilus influenzae type b. Infect. Imun. 44: 452–458 (1984).
Sutton, A.R., Schneerson, R., Kendall-Morris, S., and Robbins, J.B. Differential complement resistance mediates virulence of Haemophilus influenzae type b. Infect. Immun. 35: 95–104 (1982).
Tarr, P.I., Hosea, S.W., Brown, E.J., Schneerson, R., Sutton, A., Frank, M.M. The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by an alternative pathway of complement activation. J. Immunol. 120: 1772–1775 (1982).
Thong, Y.H., Simpson, D.A., and Muller-Eberhard, H.J. Homozygous deficiency of the second component of complement presenting with recurrent bacterial meningitis. Arch. Dis. Child. 55: 471–473 (1980).
Toews, G.B., Vial, W.C. and Hansen, E.J. Role of the C5 and recruited neutrophils in early clearance of non-typable Haemophilus influenzae from murine lungs. Infect. Immun. 50: 207–212 (1985).
Weller, P.F., Smith, A.L., Smith, D.H., and Anderson, P. Role of immunity in the clearance of bacteremia due to Haemophilus influenzae. J. Infect. Dis. 138: 427–436 (1978).
Zwahlen, A., Winkelstein, J.A. and Moxon, E.R. Surface determinants of Haemophilus influenzae pathogenicity: Comparative virulence of capsular transformants in normal and complement-depleted rats. J. Infect. Dis. 148: 385–394 (1983a).
Zwahlen, A., Winkelstein, J.A., and Moxon, E.R. Participation of complement in host defense against capsule-deficient Haemophilus influenzae. Infect. Immun. 42: 708–715 (1983b).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Moxon, E.R., Winkelstein, J.A. (1988). Interaction of Haemophilus Influenzae with Complement. In: Cabello, F.C., Pruzzo, C. (eds) Bacteria, Complement and the Phagocytic Cell. NATO ASI Series, vol 24. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85718-8_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-85718-8_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-85720-1
Online ISBN: 978-3-642-85718-8
eBook Packages: Springer Book Archive